Advanced Search

Show simple item record

Switching to tenofovir alafenamide in hbv: nationwide real life data of efficacy and safety from Turkey

dc.contributor.authorTabak, Fehmi
dc.contributor.authorYörük, Gülşen
dc.contributor.authorKöksal, İftihar
dc.contributor.authorErdem, Hazal
dc.contributor.authorYıldız, Dilek
dc.contributor.authorİnce, Nevin
dc.contributor.authorYamazhan, Tansu
dc.contributor.authorSume, Serkan
dc.contributor.authorBatırel, Ayşe
dc.contributor.authorGünal, Özgür
dc.contributor.authorYıldız, İlknur Esen
dc.contributor.authorSırmatel, Fatma
dc.contributor.authorKoç, Meliha Merih
dc.contributor.authorÇeken, Sabahat
dc.contributor.authorBozkurt, İlkay
dc.contributor.authorGörenek, Levent
dc.contributor.authorŞener, Alper
dc.contributor.authorKöse, Şükran
dc.contributor.authorTürker, Kamuran
dc.contributor.authorİnan, Dilara
dc.contributor.authorKarabay, Oğuz
dc.contributor.authorGüner, Rahmet
dc.date.accessioned2022-09-20T13:04:02Z
dc.date.available2022-09-20T13:04:02Z
dc.date.issued2021en_US
dc.identifier.citationTabak, F., Yörük, G., Köksal, İ., Erdem, H., Yıldız, D., İnce, N.,...Güner, R. (n.d.). Switching to tenofovir alafenamide in hbv: nationwide real life data of efficacy and safety from Turkey. https://www.webofscience.com/wos/woscc/full-record/WOS:000707188002220
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.urihttps://hdl.handle.net/20.500.12428/3731
dc.description.abstractTenofovir alafenamide (TAF) is a new prodrug of tenofovir used for the treatment of HIV-1 and HBV infections. It provides more efficient intracellular tenofovir concentrations at a relatively lower dose than provided by tenofovir disoproxil fumarate (TDF). TAF is expected to have efficacy similar to that of TDF with improved safety profile.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTenofovir alafenamide (TAF)en_US
dc.subjectProdrugen_US
dc.subjectHIV-1en_US
dc.subjectHBV infectionsen_US
dc.titleSwitching to tenofovir alafenamide in hbv: nationwide real life data of efficacy and safety from Turkeyen_US
dc.typeconferenceObjecten_US
dc.authorid0000-0003-2774-8601en_US
dc.relation.ispartofHepatologyen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.identifier.volume74en_US
dc.identifier.startpage497Aen_US
dc.identifier.endpage498Aen_US
dc.institutionauthorŞener, Alper
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.authorwosidF-6427-2011en_US
dc.authorscopusid23996235800en_US
dc.identifier.wosqualityQ1en_US
dc.identifier.wosWOS:000707188002220en_US


Files in this item

Thumbnail
Name:
Alper_Sener_KonferansOgesi.pdf
Size:
758.6Kb
Format:
PDF
Description:
Konferans Ögesi
View/Open

This item appears in the following Collection(s)

Show simple item record